Akoya Biosciences Inc (AKYA)
2.13
+0.01
(+0.47%)
USD |
NASDAQ |
Nov 22, 13:10
Akoya Biosciences Debt to Equity Ratio: 5.568 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.568 |
| June 30, 2024 | 3.402 |
| March 31, 2024 | 2.306 |
| December 31, 2023 | 1.400 |
| September 30, 2023 | 1.030 |
| June 30, 2023 | 0.8851 |
| March 31, 2023 | 1.506 |
| December 31, 2022 | 1.080 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.702 |
| June 30, 2022 | 0.4685 |
| March 31, 2022 | 0.3057 |
| December 31, 2021 | 0.2676 |
| September 30, 2021 | 0.2356 |
| June 30, 2021 | 0.2182 |
| March 31, 2021 | -0.5771 |
| December 31, 2020 | -0.6765 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.6765
Minimum
Dec 2020
5.568
Maximum
Sep 2024
1.132
Average
0.7935
Median
Debt to Equity Ratio Benchmarks
| Bruker Corp | 1.271 |
| Azenta Inc | 0.00 |
| Harvard Bioscience Inc | 0.5796 |
| Bionano Genomics Inc | 0.306 |
| Singular Genomics Systems Inc | 0.0419 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 129.97M |
| Total Liabilities (Quarterly) | 116.34M |
| Shareholders Equity (Quarterly) | 13.63M |
| Current Ratio | 2.746 |
| Net Debt Paydown Yield | -1.82% |